Next generation: tuberculosis vaccines that elicit protective CD8+ T cells - Wikidata - wikimedia - TriplyDB

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

http://www.wikidata.org/entity/Q35099708

about

Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes.A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.Is intranasal vaccination a feasible solution for tuberculosis?CD8 T cells and Mycobacterium tuberculosis infection.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells.How could we have better vaccines against tuberculosis?Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses Live tuberculosis vaccines based onphoPmutants: a step towards clinical trials

P2860

Q28476716-A86B4464-CCC5-4292-8D04-8FC9F9B254F6 Q35097409-E340A38A-8ACC-4DFD-BDF0-840707412A22 Q35599219-51F87AF5-3D31-4C81-8DA4-05E142C9B2C9 Q35887180-D9EEC0A1-A879-48F9-BD71-64B67952A319 Q36909492-56D91704-4764-407B-95E4-E9389FF5B46F Q36972511-38CE30AA-7777-4216-8DCB-06BBCFDECCE5 Q37155566-159A7E3B-AD11-4255-8F75-73D3C66C80BC Q37186090-65EA207E-C184-4D37-AB6F-AACD761E4D27 Q37316013-ACFC51F2-4E8B-40A7-90AC-48106BE06CF0 Q38445065-C5AF7308-FE88-41DA-BEDA-93B1AD7EBF27 Q41645299-5BA425E9-5837-4489-8379-0AA2D676B563 Q47605682-CC7FF00D-D8BF-4441-A1C6-A40DDC66C1E8 Q57112024-2C8FD90B-1C0A-4527-A213-1B1AEA992581 Q57209233-DCBE9D98-600B-4929-BD22-577712227A37 Q58834940-04CBC5F6-D8ED-47DF-B75C-6BBF74EDCCBB

P2860

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

http://www.wikidata.org/entity/Q35099708

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@ast

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@en

type

label

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@ast

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@en

prefLabel

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@ast

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@en

P1433

Q35099708-FBA4C586-621D-45BE-9B15-84E0B07424D6

P1476

Q35099708-98D543B3-4045-4568-BB80-374E8D3374CE

P2093

Q35099708-014D88B2-9F8E-4881-A5C4-E186A9A43105

Q35099708-FFB293FA-EF44-4014-8926-ED9B8A42DF64

P2860

Q35099708-00DF7981-3805-4251-9936-3981737EAE4D

Q35099708-02523291-6F66-406F-862A-6E60FA2E107D

Q35099708-05568566-9BAF-49F8-93DB-3AC63CF18835

Q35099708-09CD191E-2F92-4E42-B875-8A570A09115A

Q35099708-0AF89943-F851-472C-B2E5-6DDB6313EF2E

Q35099708-0B6147E5-0305-460E-ADFC-9F244714975D

Q35099708-1118ECF9-4406-4FC2-B985-9C0C64B758E5

Q35099708-11439F1A-17F7-40BB-B17B-F8C76BE42110

Q35099708-131D2B96-D79B-43E0-B06A-3B2D25AA6B88

Q35099708-158A9FAF-1348-4EC1-A909-CC763EF43796

P304

Q35099708-B39BF087-6BDF-4CAB-B104-703A5D4C7C91

P31

Q35099708-61298046-41C6-4873-9C6F-519BE71BEF44

P356

Q35099708-240521DB-B4DA-46A7-8B16-939EB6E431B9

P433

Q35099708-7B6F45D2-AD95-4573-BBE0-5112A13F1FA2

P478

Q35099708-BF6F4C74-A903-474B-A490-6C0A238103C7

P50

Q35099708-5E8A17F4-FEB0-4121-AA69-BBFAB7C04E71

P577

Q35099708-57D9F5F6-E60E-4252-9F97-F82D79BBFFA1

P5875

Q35099708-2F3D7D28-DA8C-4A72-9F2F-CB336B2208D9

P698

Q35099708-17B59E6F-F376-4D35-87A0-0B874560BAAA

P921

Q35099708-128810EC-050B-420D-AA69-B556C0BAF1BE

P932

Q35099708-905A3588-A85B-4F06-9D01-753F040F9476

P356

14760584.6.3.441

P1433

Expert Review of Vaccines

P1476

Next generation: tuberculosis vaccines that elicit protective CD8+ T cells

@en

P2093

Joshua S M Woodworth

http://www.w3.org/2001/XMLSchema#string

Ying Wu

http://www.w3.org/2001/XMLSchema#string

P2860

A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis

Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family

Dendritic cells: specialized and regulated antigen processing machines

Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.

Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection

Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis.

P304

441-456

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.6.3.441

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Samuel M. Behar

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6293165

http://www.w3.org/2001/XMLSchema#string

P698

17542758

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

3134449

http://www.w3.org/2001/XMLSchema#string